Using Your Phone While on the Toilet May Raise Risk of Hemorrhoids
Share on PinterestHemorrhoids are common, but spending less time on the toilet with your phone can help lower your risk. ...
Anemia Predicts Risks for Readmission and Mortality in COPD
In patients with acute exacerbations of chronic obstructive pulmonary disease, anemia is common and linked to increased 1-year readmission and ...
Quantum router could speed up quantum computers
A false colour image of the quantum router circuitMIT SQUILL foundry Quantum computers may be able to run useful algorithms ...
High Relapse Risk in Diabetic Foot Ulcers
High rates of recurrence of DFUs and reintervention for chronic limb-threatening ischemia impose a notable, unrecognized burden on patients and ...
LSD-Based Med Safe, Effective for Anxiety in Phase 2B Trial
Compared with placebo, a single application of the LSD-based medication MM120 is linked to rapidly reduced anxiety and depressive symptoms ...
Weight-Loss Drugs for Polycythemia Vera?
Semaglutide and other GLP-1 receptor agonists show robust benefit in polycythemia vera, but it’s unclear whether this is due to ...
Trial Uncertainties With New Cancer Drugs Rarely Reported
Nearly 80% of cancer drugs approved by the FDA in recent years have clinical trial uncertainties, but journals and guidelines ...
Birmingham lab ‘revolutionising’ maternity training, says NHS
Amy ColeMidlands Today andTanya GuptaBBC News, West MidlandsBBCStaff practise on Linda the mannequin in the simulation laboratoryA simulation laboratory that ...
Malnutrition and Infection Rates Increase Before IBD Surgery
A retrospective study finds that rates of malnutrition and other adverse clinical outcomes are higher 1 month before surgery than ...
Overall Survival Win for Osimertinib-Chemotherapy in First-Line EGFR-Mutated NSCLC
(MedPage Today) -- First-line osimertinib (Tagrisso) plus chemotherapy significantly improved survival versus osimertinib monotherapy in patients with EGFR-mutated advanced non-small ...
First-Line Osimertinib Plus Chemo Extends Survival in NSCLC
The FLAURA2 trial establishes a new standard of care for EGFR-mutated NSCLC, according to the authors of new research. Medscape ...
NSCLC Survival Benefit Seen With EGFR-TKI + Chemo
Median PFS benefit was just over 3 months in patients with EGFR-mutant NSCLC who had tumor suppressor gene co-mutations. Medscape ...
Disabled doctors consider leaving NHS over shift inflexibility
Jenny ReesHealth correspondent, BBC WalesBritish Medical AssociationDr Alice Gatenby has been told "it's too much hassle" to change shifts to ...
Fracture Protection May Be Another Benefit of GLP-1 Receptor Agonists
(MedPage Today) -- SEATTLE -- GLP-1 receptor agonist use was tied with a reduced risk for fracture among older women ...
Few Long-Term Bone Consequences After Teen Bariatric Surgery
(MedPage Today) -- SEATTLE -- Adolescents and young adults who underwent metabolic and bariatric surgery had lower bone mineral density ...
‘I Don’t Know How Many Died’: What We Heard This Week
(MedPage Today) -- "I don't know how many died." -- HHS Secretary Robert F. Kennedy Jr. during a Senate hearing ...
Osimertinib’s Benefits in NSCLC Can Extend Beyond First Line
Patients with EGFR-mutated NSCLC who progress on first-line osimertinib live longer without disease worsening when the drug is maintained alongside ...
Do I Have to Go Abroad for a COVID Booster?
(MedPage Today) -- The Trump administration has once again inserted politics into medicine -- this time by narrowing the indications ...
Perioperative Nivolumab Does Not Sacrifice QoL in NSCLC
Perioperative nivolumab in eligible patients with resectable non-small cell lung cancer offers improved survival outcomes and preserves quality of life, ...
High Childhood Blood Pressure May Predict Risk of Early CVD Mortality
(MedPage Today) -- Elevated blood pressure in childhood was tied to a greater risk of early death from cardiovascular disease ...
